AzTrials
AzTrials

Pelvic Organ ProlapseNCT04009694

Does a High BMI Affect Supervised Pelvic Floor Muscle Training for Improving Symptoms in Women With Various Stages of Pelvic Organ Prolapse?

A study testing Pelvic Floor Muscle training in people with Pelvic Organ Prolapse and Uterine Prolapse, run by University of Salford at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The trial design is a quasi-experimental cohort trial that includes women referred for pelvic organ prolapse specific physiotherapy. Candidates will be selected via a convenience sampling method from four physiotherapy outpatient departments at a NHS trust within Greater Manchester. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Pelvic Floor Muscle training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited Kingdom
Study dates
1 Sep 2018to 10 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Gynaecologist diagnosed women with a mild / moderate or severe pelvic organ prolapse
  • >18 years old

Who cannot join

  • Unwilling or unable to provide informed consent (opt out of treatment)
  • Unable to contract the pelvic floor muscles (determined by the treating physiotherapist)
  • History of Pelvic cancer / or radiotherapy treatment within three months,
  • Neurological or psychiatric disorders,
  • Untreated urinary tract infections,
  • Pregnant or planning to become pregnant or given birth within the past year,
  • Recent vaginal surgery within twelve weeks or evidence of genital oedema,
  • Suspected infection or fragility of the genital area As indicated by the referral source or patient reported at the initial assessment.

Trial locations and contacts

1 site in 1 country.

Rebecca C Whittle, MSc contact

0161 7202423

R.Hadfield1@edu.salford.ac.uk

Nicky Spence, PhD contact

N.Spence@salford.ac.uk

United Kingdom1 site, 1 recruiting
  • National Health Service

    Manchester, M8 5RB

    Rebecca C Whittle, MSc, 0161 720 2423, R.Hadfield1@edu.salford.ac.uk

    Recruiting

Other trials in United Kingdom

About this study

The trial design is a quasi-experimental cohort trial that includes women referred for pelvic organ prolapse specific physiotherapy.

Candidates will be selected via a convenience sampling method from four physiotherapy outpatient departments at a NHS trust within Greater Manchester. The data collection occurred in January-June 2019 and ethical approval was granted by School Research Ethics, University of Salford.

Read more

Treatment aims to ensure there is respect for their autonomy, treatment is fair (Justice), no harm is done to the participant (nonmaleficence) and treatment benefits the participants (beneficence).

Participants are required to complete a consent form prior to their initial session. To ensure methodological quality, the STROBE guidelines will be followed to make certain all apt information required is reported to allow for replication of the intervention.

The trial aims to include (n=60) women with a diagnosed pelvic organ prolapse. They are required to complete 16 weeks of supervised pelvic floor exercises with a specialist physiotherapist as documented within the most recent NICE guidelines.

The outcome measures used will be the Pelvic Organ Prolapse symptom score (POPSS) and this will be documented before and after the 16 week period.

Along side the POPSS, the patients body mass index and severity of pelvic organ prolapse will also be recorded and the results of this will be correlated post trial using the relevant data analysis testing methods.

Being tested
Pelvic Floor Muscle training
Keywords
Pelvic floor muscle training, pelvic physiotherapy, pelvic floor exercises
Medical subject headings
Pelvic Organ Prolapse, Uterine Prolapse, Prolapse, Cystocele, Rectocele

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pelvic Floor Muscle trainingOther

    Sixteen weeks of supervised pelvic floor muscle training with a specialist physiotherapist

Study groups in NCT04009694
Study groupRoleWhat they receive
Pelvic Floor Muscle TrainingExperimentalSixteen weeks of supervised pelvic floor muscle training with a specialist physiotherapist. Participants will be assessed at weeks 0 / 4 / 10 \& 16 and the outcome measures will be recorded at week 0 \& week 16. During each assessment, participants will be educated regarding the anatomy of pelvic organ prolapses and the pelvic floor muscles. They will be taught how to contract their pelvic floor, offered a vaginal examination, given a personalised pelvic floor muscle training programme (including the Knack) - up to a ten second hold long contractions (x 10 repitations) and up to 10 quick contractions. They will also be taught a sub max contraction for up to 30 seconds, offered lifestyle management advice including avoiding heavy lifting or straining. A leaflet explaining the aforementioned information will also be provided at the initial assessment.
Receives: Other: Pelvic Floor Muscle training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pelvic Organ Prolapse Symptom Score (POPSS)

    The POPSS is a patient-reported Outcome Measure consisting of seven POP symptom specific items, each with a five-point Likert response set (0 = never, 1 = occasionally, 2 = sometimes, 3 = most of the time and 4 = all of the time). The minimum score is 0 which would indicate that the pelvic organ prolapse in a-symptomatic and the maximum score for the POPSS is 28 which would indicate higher severity in pelvic organ prolapse symptoms. In addition, the women select a specific symptom which is most bothersome for them.

    Measured: sixteen weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2019
  2. Study start1 Sep 2018
  3. Primary completion1 Sep 2019 (estimated)
  4. Study completion10 Sep 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04009694
Sponsor's protocol ID
USalford1
Status last verified
Jul 2019
First submitted
2 Jul 2019
Last updated
9 Jul 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Pelvic Floor Muscle training in people with Pelvic Organ Prolapse and Uterine Prolapse, run by University of Salford at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rebecca C Whittle, MSc (0161 7202423, R.Hadfield1@edu.salford.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pelvic Organ Prolapse Symptom Score (POPSS) (time frame: sixteen weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04009694 | AzTrials